I had 2000MG of BioTE Pellets put in (10 pellets). Bloodwork from 10-10-2016 or 2 1/2 weeks in. I have slept great..... and been trying to work out. But have had anxiety spikes. Doc says its not from T....but to double DIM to 300mg a day. My Estradiol was 45 on 10-01-16 and now is 72. Anything else below look concerning? Previously on 10/1/2016 TT was 1491 and Free T was 27.6 - so they have both grown. Is there any concern of too much T or Free T? I don't like this anxiety for sure!
CBC With Differential/Platelet
WBC 4.7 3.4-10.8 x10E3/uL 01
RBC 4.45 4.14-5.80 x10E6/uL 01
Hemoglobin 14.7 12.6-17.7 g/dL 01
Hematocrit 43.2 37.5-51.0 % 01
MCV 97 79-97 fL 01
MCH 33.0 26.6-33.0 pg 01
MCHC 34.0 31.5-35.7 g/dL 01
RDW 13.7 12.3-15.4 % 01
Platelets 225 150-379 x10E3/uL 01
Neutrophils 49 % 01
Lymphs 38 % 01
Monocytes 9 % 01
Eos 4 % 01
Basos 0 % 01
Neutrophils (Absolute) 2.3 1.4-7.0 x10E3/uL 01
Lymphs (Absolute) 1.8 0.7-3.1 x10E3/uL 01
Monocytes(Absolute) 0.4 0.1-0.9 x10E3/uL 01
Eos (Absolute) 0.2 0.0-0.4 x10E3/uL 01
Baso (Absolute) 0.0 0.0-0.2 x10E3/uL 01
Immature Granulocytes 0 % 01
Immature Grans (Abs) 0.0 0.0-0.1 x10E3/uL 01
Comp. Metabolic Panel (14)
Glucose, Serum 96 65-99 mg/dL 01
BUN 16 6-24 mg/dL 01
Creatinine, Serum 0.91 0.76-1.27 mg/dL 01
eGFR If NonAfricn Am 99 >59 mL/min/1.73 01
eGFR If Africn Am 115 >59 mL/min/1.73 01
BUN/Creatinine Ratio 18 9-20 01
Sodium, Serum 143 134-144 mmol/L 01
**Effective October 17, 2016 the reference interval**
for Sodium, Serum will be changing to:
136 - 144
Potassium, Serum 4.4 3.5-5.2 mmol/L 01
**Effective October 17, 2016 the reference interval**
for Potassium, Serum will be changing to:
0 - 7 days 3.7 - 5.2
8 - 30 days 3.7 - 6.4
1 - 6 months 3.8 - 6.0
7 months - 1 year 3.8 - 5.3
>1 year 3.5 - 5.2
Chloride, Serum 104 97-108 mmol/L 01
**Effective October 17, 2016 the reference interval**
for Chloride, Serum will be changing to:
97 - 106
Carbon Dioxide, Total 24 18-29 mmol/L 01
Calcium, Serum 9.1 8.7-10.2 mg/dL 01
Protein, Total, Serum 6.5 6.0-8.5 g/dL 01
Albumin, Serum 4.3 3.5-5.5 g/dL 01
Globulin, Total 2.2 1.5-4.5 g/dL 01
A/G Ratio 2.0 1.1-2.5 01
1 of 2
Bilirubin, Total 0.4 0.0-1.2 mg/dL 01
Alkaline Phosphatase, S 55 39-117 IU/L 01
AST (SGOT) 22 0-40 IU/L 01
ALT (SGPT) 24 0-44 IU/L 01
Lipid Panel
Cholesterol, Total 134 100-199 mg/dL 01
Triglycerides 81 0-149 mg/dL 01
HDL Cholesterol 38 LOW >39 mg/dL 01
According to ATP-III Guidelines, HDL-C >59 mg/dL is considered a
negative risk factor for CHD.
VLDL Cholesterol Cal 16 5-40 mg/dL 01
LDL Cholesterol Calc 80 0-99 mg/dL 01
Thyroid Panel With TSH
TSH 3.270 0.450-4.500 uIU/mL 01
Thyroxine (T4) 8.1 4.5-12.0 ug/dL 01
T3 Uptake 34 24-39 % 01
Free Thyroxine Index 2.8 1.2-4.9 01
Testosterone, Free/Tot Equilib
Testosterone, Serum >1500 HIGH 348-1197 ng/dL 01
Comment: Comment 01
Adult male reference interval is based on a population of lean males
up to 40 years old.
Testosterone,Free >35.70 HIGH 5.00-21.00 ng/dL 02
% Free Testosterone 2.38 1.50-4.20 % 02
Prostate-Specific Ag, Serum
Prostate Specific Ag, Serum 1.0 0.0-4.0 ng/mL 01
Roche ECLIA methodology.
.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.
IGF-1
Insulin-Like Growth Factor I 171 67-205 ng/mL 02
Estradiol, Sensitive
Estradiol, Sensitive 72.9 HIGH 8.0-35.0 pg/mL 02
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared by the Food and
Drug Administration.
Methodology: Liquid chromatography tandem mass spectrometry(LC/MS/MS)
Performing Laboratory Information:
01: LabCorp Tampa, 5610 W LaSalle Street, Tampa FL, phone: 800-877-5227
Medical Director: MD Sean Farrier
02: LabCorp Burlington, 1447 York Court, Burlington NC, phone: 800-762-4344
Medical Director: MD William F Hancock
2
CBC With Differential/Platelet
WBC 4.7 3.4-10.8 x10E3/uL 01
RBC 4.45 4.14-5.80 x10E6/uL 01
Hemoglobin 14.7 12.6-17.7 g/dL 01
Hematocrit 43.2 37.5-51.0 % 01
MCV 97 79-97 fL 01
MCH 33.0 26.6-33.0 pg 01
MCHC 34.0 31.5-35.7 g/dL 01
RDW 13.7 12.3-15.4 % 01
Platelets 225 150-379 x10E3/uL 01
Neutrophils 49 % 01
Lymphs 38 % 01
Monocytes 9 % 01
Eos 4 % 01
Basos 0 % 01
Neutrophils (Absolute) 2.3 1.4-7.0 x10E3/uL 01
Lymphs (Absolute) 1.8 0.7-3.1 x10E3/uL 01
Monocytes(Absolute) 0.4 0.1-0.9 x10E3/uL 01
Eos (Absolute) 0.2 0.0-0.4 x10E3/uL 01
Baso (Absolute) 0.0 0.0-0.2 x10E3/uL 01
Immature Granulocytes 0 % 01
Immature Grans (Abs) 0.0 0.0-0.1 x10E3/uL 01
Comp. Metabolic Panel (14)
Glucose, Serum 96 65-99 mg/dL 01
BUN 16 6-24 mg/dL 01
Creatinine, Serum 0.91 0.76-1.27 mg/dL 01
eGFR If NonAfricn Am 99 >59 mL/min/1.73 01
eGFR If Africn Am 115 >59 mL/min/1.73 01
BUN/Creatinine Ratio 18 9-20 01
Sodium, Serum 143 134-144 mmol/L 01
**Effective October 17, 2016 the reference interval**
for Sodium, Serum will be changing to:
136 - 144
Potassium, Serum 4.4 3.5-5.2 mmol/L 01
**Effective October 17, 2016 the reference interval**
for Potassium, Serum will be changing to:
0 - 7 days 3.7 - 5.2
8 - 30 days 3.7 - 6.4
1 - 6 months 3.8 - 6.0
7 months - 1 year 3.8 - 5.3
>1 year 3.5 - 5.2
Chloride, Serum 104 97-108 mmol/L 01
**Effective October 17, 2016 the reference interval**
for Chloride, Serum will be changing to:
97 - 106
Carbon Dioxide, Total 24 18-29 mmol/L 01
Calcium, Serum 9.1 8.7-10.2 mg/dL 01
Protein, Total, Serum 6.5 6.0-8.5 g/dL 01
Albumin, Serum 4.3 3.5-5.5 g/dL 01
Globulin, Total 2.2 1.5-4.5 g/dL 01
A/G Ratio 2.0 1.1-2.5 01
1 of 2
Bilirubin, Total 0.4 0.0-1.2 mg/dL 01
Alkaline Phosphatase, S 55 39-117 IU/L 01
AST (SGOT) 22 0-40 IU/L 01
ALT (SGPT) 24 0-44 IU/L 01
Lipid Panel
Cholesterol, Total 134 100-199 mg/dL 01
Triglycerides 81 0-149 mg/dL 01
HDL Cholesterol 38 LOW >39 mg/dL 01
According to ATP-III Guidelines, HDL-C >59 mg/dL is considered a
negative risk factor for CHD.
VLDL Cholesterol Cal 16 5-40 mg/dL 01
LDL Cholesterol Calc 80 0-99 mg/dL 01
Thyroid Panel With TSH
TSH 3.270 0.450-4.500 uIU/mL 01
Thyroxine (T4) 8.1 4.5-12.0 ug/dL 01
T3 Uptake 34 24-39 % 01
Free Thyroxine Index 2.8 1.2-4.9 01
Testosterone, Free/Tot Equilib
Testosterone, Serum >1500 HIGH 348-1197 ng/dL 01
Comment: Comment 01
Adult male reference interval is based on a population of lean males
up to 40 years old.
Testosterone,Free >35.70 HIGH 5.00-21.00 ng/dL 02
% Free Testosterone 2.38 1.50-4.20 % 02
Prostate-Specific Ag, Serum
Prostate Specific Ag, Serum 1.0 0.0-4.0 ng/mL 01
Roche ECLIA methodology.
.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.
IGF-1
Insulin-Like Growth Factor I 171 67-205 ng/mL 02
Estradiol, Sensitive
Estradiol, Sensitive 72.9 HIGH 8.0-35.0 pg/mL 02
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared by the Food and
Drug Administration.
Methodology: Liquid chromatography tandem mass spectrometry(LC/MS/MS)
Performing Laboratory Information:
01: LabCorp Tampa, 5610 W LaSalle Street, Tampa FL, phone: 800-877-5227
Medical Director: MD Sean Farrier
02: LabCorp Burlington, 1447 York Court, Burlington NC, phone: 800-762-4344
Medical Director: MD William F Hancock
2
